EV/EBITDA Multiple: MiMedx Group (MDXG)

Corporate company logo of mimedx.com (MDXG)

MiMedx Group, Inc. relies on stable cash flows from the sale of surgical biomaterials. High margins are driven by the integration of placental products into clinics, which creates purchasing inertia. Meanwhile, tissue procurement and monitoring are delegated to external partners under strict SLA control. The EV/EBITDA multiple for this heavy business helps filter out market noise, and its latest reading stands at 0.00.

MDXG (MiMedx Group Inc) Enterprise Value to Operating Income Before Depreciation Ratio history from 11/23/2025 to 11/12/2026

mimedx.com (MDXG) - metric breakdowns and financial figures

- market price and analyst price targets:
Price Chart MiMedx Group|MDXG - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization MiMedx Corp|MDXG - Total Enterprise Value
- issuer book value statistics:
Accounting Value per Share MiMedx|MDXG - Total Net Assets|Market Capitalization to Book Value Ratio mimedx.com|MDXG - Company Total Assets
- debt and liquidity data:
Total Debt to Capital MiMedx Group, Inc.|MDXG - Long-Term Debt to Equity|Short-Term Debt to Equity MiMedx|MDXG - Company Cumulative Debt|Debt to Book Capitalization Ratio MiMedx Corp|MDXG - Company Long-Term Debt|Company Short-Term Debts MiMedx|Quick Liquidity mimedx.com
- net income and valuation multiples indicators:
MDXG - Net Financial Result|Expected Profit MiMedx Group, Inc.|MDXG - Price to Earnings Ratio|Future Price to Earnings MiMedx Group, Inc.|MDXG - Price/Earnings to Growth Multiple|EV/EBITDA Multiple MiMedx Corp|MDXG - Operating income before deduction of amortization|Earnings per share for the last twelve months MiMedx|MDXG - Net earnings per share for the last 12 months|Quarterly EPS earnings growth mimedx.com|MDXG - Earnings per share growth rate in current year|Earnings growth forecast for next year MiMedx Group, Inc.
Initial company analysis:MDXG (MiMedx Group)
Product sample of MiMedx

Steady demand for placental biologics from MiMedx Group, Inc. (MDXG) ensures a consistent cash flow, making the EV/EBITDA metric for this capital-intensive business a key tool for monitoring debt leverage. The ratio of enterprise value to earnings before interest, taxes, depreciation, and amortization allows investors to assess the real value of assets relative to their ability to act as a cash generator, revealing either a hidden margin of safety or the risk of yield degradation.

Who MiMedx Group, Inc. competes with

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ascendis Pharma Inc. ASND|MDGL - Enterprise Value to EBITDA Ratio|Corcept Therapeutics - EV/EBITDA Multiple|Company Value to EBITDA rhythmtx.com|AKRO (Akero) - Enterprise Value to EBITDA Ratio|MTSR: Enterprise Value to Operating Income Before Depreciation Ratio|MLTX (MoonLake Pharma) - EV/EBITDA Multiple|EV/EBITDA Multiple Crinetics Corp|EV/EBITDA Multiple NAMS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SLNO (soleno.life)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Amicus Therapeutics, Inc. FOLD|89bio Inc (ETNB) - Company Value to EBITDA|AGIO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GPCR: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|RZLT: EV/EBITDA Multiple|LXRX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MBX Biosciences|Altimmune Inc (ALT) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aardvark Therapeutics Corp (AARD)|Enterprise Value to EBITDA Ratio Sagimet Biosciences Inc SGMT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BioAge Labs, Inc. BIOA|BMEA - Enterprise Value to EBITDA Ratio|Quince - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Fractyl Health Inc. GUTS|vtvtherapeutics.com (VTVT) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Agape ATP|PLUR (Pluristem Therapeutics) - EV/EBITDA Multiple|Company Value to EBITDA Synlogic Corp SYBX|EV/EBITDA Multiple LPCN|matinasbiopharma.com - Enterprise Value to Operating Income Before Depreciation|Spruce Biosciences - Enterprise Value to EBITDA Ratio|GLTO: Enterprise Value to Operating Income Before Depreciation|CTCX: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation LUMO (lumos-pharma.com)|ONVO: EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Radius Recycling Inc. RDUS